University of Ioannina
Επίδραση εμμηνόπαυσης και ορμονικής θεραπείας υποκατάστασης σε δείκτες αγγειακής λειτουργίας και φλεγμονής: ρόλος γενετικών πολυμορφισμών οιστρογονικών υποδοχέων
Abstract
dc:descriptionAim. To investigate the effects of menopausal transition and hormone replacement therapy (HRT) on subclini-cal atherosclerosis (vascular function and inflammation) indices in early menopausal women. Furthermore, we investigated the association of common genetic polymorphisms of estrogen receptors (ER) and subclinical atherosclerosis indices in menopausal women as well as the effects of HRT. Methods. 120 healthy early menopausal women (<3 years in menopause, <55 years old) were compared to 24 healthy age-matched premenopausal women. Menopausal women who presented clinically important vasomo-tor complaints (n=89) participated in the intervention study that included the use of HRT (transdermal 17β-estradiol 50 mcg daily plus progesterone 200 mg pos cyclically) for 3 months (40 received HRT, 44 did not receive HRT). Common carotid intima-media thickness (IMT) and flow-mediated dilation (FMD) (endothe-lium-dependent vasodilation) in the brachial artery were assessed using ultrasound. Intercellular adhesion molecule-1 (ICAM-1), P-Selectin, sCD40L and C-reactive protein were used as vascular inflammation indices. Finally, genotype analysis of polymorphisms PvuII 454-397T>C and XbaI 454-351A>G of estrogen receptor α and AluI G1730A of estrogen receptor β was also performed. Results. Early menopausal women had lower FMD and increased levels of P-Selectin and sCD40L without significant differences in IMT compared to premenopausal women. The presence and severity of vasomotor symptoms (hot flushes) were important independent predictors of vascular function and inflammation indices. Menopausal women with clinically important hot flushes had lower FMD compared to premenopausal and menopausal women with no/mild symptoms. Menopausal women with hot flushes showed higher levels of P-Selectin and sCD40L compared to premenopausal or menopausal women with no symptoms. ER polymor-phisms did not show any correlation with vascular function and inflammation indices at baseline. In meno-pausal women, HRT resulted in a significant increase in FMD and decrease in ICAM-1, P-Selectin and sCD40L compared to women who did not receive HRT. ERα and β polymorphisms were associated with HRT-induced changes in endothelial function and inflammation indices. The presence of ERα XbaI GG and ERβ AluIGG genotypes were associated with smaller HRT-induced improvements in sCD40L and FMD respec-tively. Conclusions. Healthy early menopausal women showed a deterioration of endothelial function and inflamma-tion indices without a concomitant increase in cIMT (structural disease). The presence and severity of hot flushes were related to endothelial dysfunction and increased markers of inflammation and could be an impor-tant marker of increased cardiovascular risk in early menopausal women. Short-term administration of HRT was efficient in improving markers of subclinical atherosclerosis. Early menopausal women with clinically important hot flushes could be the group of women that may benefit the most from HRT in cardiovascular prognosis. The presence of specific genetic polymorphisms of ER α and β may be related to the efficacy of HRT in improving vascular function and inflammation indices.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bechlioulis, Aris
- Μπεχλιούλης, Άρης
Subjects
dc:subject × 22- Εμμηνόπαυση
- Οιστρογόνα
- Αθηροσκλήρωση
- Ενδοθηλιακή λειτουργία
- Αγγειακή φλεγμονή
- Πάχος έσω-μέσου χιτώνα καρωτίδων
- Ορμονική θεραπεία υποκατάστασης
- Γενετικοί πολυμορφισμοί οιστρογονικών υποδοχέων
- Menopause
- Estrogens
- Atherosclerosis
- Endothelial function
- Vascular inflammation
- Carotid intima-media thickness
- Hormone replacement therapy
- Estrogen receptor gene polymorphisms
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27819